Cliff Asness's TMDX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 4,808 shares of TransMedics Group, Inc. (TMDX) worth $584,894, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in TMDX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 6,154 shares. Largest reduction occurred in Q4 2024, reducing 4,937 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's TransMedics Group (TMDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly TransMedics Group (TMDX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -3,789 | Reduce 44.07% | 4,808 | $121.65 |
| Q3 2025 | +3,629 | Add 73.05% | 8,597 | $112.20 |
| Q2 2025 | +4,968 | New Buy | 4,968 | $134.01 |
| Q1 2025 | -4,232 | Sold Out | 0 | $0.00 |
| Q4 2024 | -4,937 | Reduce 53.84% | 4,232 | $62.35 |
| Q3 2024 | +6,154 | Add 204.11% | 9,169 | $157.00 |
| Q2 2024 | -353 | Reduce 10.48% | 3,015 | $150.62 |
| Q1 2024 | -2,935 | Reduce 46.57% | 3,368 | $73.94 |
| Q4 2023 | +223 | Add 3.67% | 6,303 | $78.93 |
| Q3 2023 | -1,369 | Reduce 18.38% | 6,080 | $54.75 |
| Q2 2023 | +882 | Add 13.43% | 7,449 | $83.98 |
| Q1 2023 | +1,197 | Add 22.29% | 6,567 | $75.73 |
| Q4 2022 | -957 | Reduce 15.13% | 5,370 | $61.72 |
| Q3 2022 | +6,327 | New Buy | 6,327 | $41.73 |
Cliff Asness's TransMedics Group Investment FAQs
Cliff Asness first purchased TransMedics Group, Inc. (TMDX) in Q3 2022, acquiring 6,327 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held TransMedics Group, Inc. (TMDX) for 14 quarters since Q3 2022.
Cliff Asness's largest addition to TransMedics Group, Inc. (TMDX) was in Q3 2022, adding 6,327 shares worth $264,000.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 4,808 shares of TransMedics Group, Inc. (TMDX), valued at approximately $584,894.
As of the Q4 2025 filing, TransMedics Group, Inc. (TMDX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in TransMedics Group, Inc. (TMDX) was 9,169 shares, as reported at the end of Q3 2024.